<ѻý>Voclosporin Benefits in Nephritis Persist at 30 Monthsѻý> No new safety signals seen in long-term extension for lupus nephritis Nov 09, 2021
<ѻý>Avacopan Helps Vasculitis Patients With Renal Impairment Wean Off Steroidsѻý> Patients saw better eGFR recovery compared with prednisone Nov 08, 2021
<ѻý>Vitamin D and Disease Prevention: Worth Another Look?ѻý> Incidence of autoimmune disease decreased by 25-30% with dietary supplements Nov 08, 2021
<ѻý>Guselkumab Response Durable in Psoriatic Arthritisѻý> Skin and joint improvements persisted through 2 years of follow-up Nov 08, 2021
<ѻý>Early Biologics Better in Juvenile Idiopathic Arthritisѻý> After 2 years, more patients on combo biologic/DMARD regimen had inactive disease Nov 08, 2021
<ѻý>Brepocitinib Shows Promise in Phase II Trial for PsAѻý> Oral tyrosine kinase 2/JAK-1 inhibitor improved both joint and skin manifestations Nov 07, 2021
<ѻý>Could This Biologic Drug Work in Patients Lacking Its Target?ѻý> Bizarre finding with omalizumab Nov 07, 2021
<ѻý>Targeting IL-23 Succeeds in Psoriatic Arthritisѻý> Patients had active, longstanding disease and inadequate responses to other agents Nov 07, 2021
<ѻý>Can Abatacept Reverse Early Rheumatoid Arthritis?ѻý> At-risk patients showed improvements in inflammation -- and also delays in disease onset Nov 06, 2021
<ѻý>Mixed Results With Anti-Interleukin Biologics in Asthmaѻý> One shows promise; another fails miserably (and mysteriously) Oct 27, 2021
<ѻý>No Love for PRP in Ankle Osteoarthritis Trialѻý> Dutch researchers throw cold water on popular therapy Oct 26, 2021
<ѻý>Following Rituximab With Second Biologic Helpful in Lupusѻý> Trial may provide answer for patients who don't respond to B-cell depletion Oct 25, 2021
<ѻý>How Should Patients With Autoimmune Diseases Approach COVID Vaccination?ѻý> Mixed messaging and a lack of tailored research leaves providers and patients in the dark Oct 22, 2021
<ѻý>First Interchangeable Humira Biosimilar Approvedѻý> Cyltezo nabs coveted "interchangeable" status for RA, inflammatory bowel disease, and more Oct 18, 2021
<ѻý>FDA Gives Thumbs Up to ANCA-Associated Vasculitis Drugѻý> Approval granted to avacopan despite advisory committee concerns Oct 08, 2021
<ѻý>Is This the Future of Corticosteroids?ѻý> Novel agent, aimed at doing away with adverse metabolic effects, proves mettle in DMD Oct 05, 2021
<ѻý>Olfactory Loss Common in Sjogren's Syndromeѻý> Objective impairments in olfaction correlated with disease activity and symptoms Sep 29, 2021
<ѻý>In RA, Little Risk for Recurrent Cancer With Biologic Treatmentѻý> Results important because most trials excluded patients with previous cancer, researchers note Sep 23, 2021
<ѻý>Statins Not Linked With Rheumatoid Arthritis, Large Study Findsѻý> Risks attenuated after adjustment for lipid levels Sep 22, 2021
<ѻý>IBD and Pediatric Arthritis: Exploring the Linkѻý> Risk factors include enthesitis, family history, and etanercept use Sep 15, 2021
<ѻý>Pneumocystis Often Lethal in Dermatomyositisѻý> Incidence of pneumonia high in MDA5-antibody-positive patients Sep 10, 2021
<ѻý>Lymphoma in RA: Disease Activity Mattersѻý> Strongest risk factors were baseline disease activity scores and bone erosions Sep 08, 2021
<ѻý>FDA Slaps Restrictions on JAK Inhibitors Over Serious Safety Risksѻý> Use for inflammatory conditions limited to those who fail on TNF blockers Sep 01, 2021
<ѻý>Fibromyalgia: A New Feature of Long COVID?ѻý> Almost one-third of patients in Italian study had musculoskeletal sequelae Aug 31, 2021
<ѻý>What's Causing Cancer Patient's Joint Pain While on Checkpoint Inhibitor?ѻý> Here is how clinicians diagnosed this rare inflammatory side effect Aug 30, 2021
<ѻý>What Factors Predict RA in First-Degree Relatives?ѻý> Study may offer insight into preclinical phase to identify factors that predict progression Aug 12, 2021
<ѻý>JAK Inhibitor Tops Mab for Eczemaѻý> New disease-modifying treatment option on the horizon Aug 04, 2021
<ѻý>Healthy Lifestyle Limits Lupus Riskѻý> Diet, exercise, weight, smoking, and moderate alcohol use contributed to lower risk in women Jul 29, 2021
<ѻý>New-Onset IBD and IL-17 Inhibitors: What Is the Risk?ѻý> Underlying inflammatory disease severity should be taken into account Jul 21, 2021
<ѻý>FDA Approves IVIG for Dermatomyositisѻý> Octagam 10% lands indication for adults following results of ProDERM trial Jul 20, 2021
<ѻý>CV Risk in PsA: Do Drugs Matter?ѻý> Study weighs in on heart safety of TNF inhibitors versus other biologics Jul 19, 2021
<ѻý>Slow Steroid Tapering Succeeds in SLEѻý> Flare rates were significantly lower with gradual withdrawal than with low-dose maintenance Jul 13, 2021
<ѻý>Effective Treatments for Hand Osteoarthritis: The Search Goes Onѻý> Hydroxychloroquine not effective as disease-modifying drug for erosive hand OA, trial confirmed Jul 08, 2021
<ѻý>Skin Rash Should Be a Huge Red Flag for LVAD Recipients, Group Saysѻý> New phenomenon suggests perils of not performing biopsy in time Jul 07, 2021
<ѻý>Rinvoq Shows Promise in Spine Diseaseѻý> 1-year results in ankylosing spondylitis demonstrate efficacy for JAK inhibitor upadacitinib Jul 02, 2021
<ѻý>Target TNF or IL-12/23 in Psoriatic Arthritis?ѻý> Both TNF inhibitors and ustekinumab were effective in real-world use Jun 30, 2021
<ѻý>New ACR Rheumatoid Arthritis Guideline: Emphasis on Methotrexateѻý> Many RA patients succeed with optimized use of the DMARD before adding another medication Jun 28, 2021
<ѻý>Pain Persists in RA, Even Without Inflammationѻý> At 5 years, one-third of patients with rheumatoid arthritis still had "unacceptable" pain Jun 22, 2021
<ѻý>Osteoarthritis: A Link With Parkinson's?ѻý> Inflammation may contribute to both joint and nerve degeneration Jun 09, 2021
<ѻý>Secukinumab Shows Promise for Kids With Arthritisѻý> More than 90% responded at week 12, study showed Jun 07, 2021